Pre-processing cultures detected certain microorganisms in donor tissue.
Source facts
Action
Consignees were first notified by telephone on 2/24/2003 with follow up letter on March 6, 2003 and were advised, if the tissue had not yet been implanted, to remove tissue from implantable inventory and place it into quarantine. CryoLife will provide specific instructions for returning the tissue. A stamped, self-addressed postcard was provided to confirm receipt of the notice and to provide information regarding the disposition of the tissue.
Initiated
2003-02-24
Root cause
Other
Terminated
2004-07-23
Distribution
Heart allografts were distributed to two hospitals in OH and Quebec, Canada.
Recall number
Z-0719-03
Recall status
Terminated
CDRH record ID
26532
FDA classified
2003-04-10
Recall event number
25819
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.